Financhill
Sell
45

VYNE Quote, Financials, Valuation and Earnings

Last price:
$0.37
Seasonality move :
-5.82%
Day range:
$0.37 - $0.38
52-week range:
$0.28 - $4.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
30.54x
P/B ratio:
0.39x
Volume:
384.6K
Avg. volume:
1.3M
1-year change:
-86.29%
Market cap:
$12.5M
Revenue:
$501K
EPS (TTM):
-$0.79

Earnings Data

Next earnings date for VYNE
--
Most recent earnings per share
-$0.17
Missed by $0.17
(Nov 7/2025)
Consensus Estimate
--
(Nov 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VYNE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2025 Q4 $200K -- -- -- --
11/07/2025 Q3 $100K $169K -$0.17 -- --
08/14/2025 Q2 $150K $69K -$0.13 -- --
05/08/2025 Q1 $50K $202K -$0.20 -- --
03/06/2025 Q4 $140K $84K -$0.28 -- --
11/07/2024 Q3 $110K $121K -$0.29 -- --
08/14/2024 Q2 $110K $198K -$0.22 -- --
05/09/2024 Q1 $100K $98K -$0.15 -- --
02/29/2024 Q4 $150K $76K -$0.44 -- --
09/30/2023 Q3 -- -- -$2.01 -- --
06/30/2023 Q2 -- -- -$3.09 -- --
03/31/2023 Q1 -- -- -$1.74 -- --
12/31/2022 Q4 -- -- -$3.33 -- --
11/10/2022 Q3 -- -- -$2.94 -$3.60 $0.66
08/12/2022 Q2 -- -- -$2.63 -$2.70 $0.07
05/06/2022 Q1 -- -- $1.51 -$2.70 $4.21
03/04/2022 Q4 -- -- -$3.96 -- --
11/10/2021 Q3 -- -- -$7.38 -- --
08/12/2021 Q2 -- -- -$7.02 -- --
05/06/2021 Q1 -- -- -$7.56 -- --
03/04/2021 Q4 -- -- $1.80 -- --
11/05/2020 Q3 -- -- -$10.62 -- --
08/06/2020 Q2 -- -- -$86.94 -- --
05/11/2020 Q1 -- -- -$68.22 -- --
03/03/2020 Q4 -- -- -$64.08 -- --
10/31/2019 Q3 -- -- -$50.40 -- --
08/01/2019 Q2 -- -- -$49.68 -- --
05/02/2019 Q1 -- -- -$58.32 -- --
02/27/2019 Q4 -- -- -$54.72 -- --
11/07/2018 Q3 -- -- -$40.32 -- --
08/01/2018 Q2 -- -- -$25.92 -- --
05/09/2018 Q1 -- -- -$51.84 -- --
03/28/2018 Q4 -- -- -$32.43 -- --
09/30/2017 Q3 -- -- -$50.99 -- --
06/30/2017 Q2 -- -- -$38.39 -- --
03/31/2017 Q1 -- -- -$34.16 -- --
12/31/2016 Q4 -- -- -$30.18 -- --

VYNE Therapeutics, Inc. Earnings Questions

  • How Much did VYNE Therapeutics, Inc. Generate in Revenue Last Quarter?

    VYNE Therapeutics, Inc. reported $169K worth of top line sales in its most recent quarter.

  • Did VYNE Therapeutics, Inc. Beat Earnings Last Quarter?

    VYNE Therapeutics, Inc. announced earnings per share of -$0.17 which represents a miss of analyst forecast a -- per share.

  • Is VYNE Therapeutics, Inc. Profitable?

    VYNE Therapeutics, Inc. reported $163K that represents $0.00 per share over the last quarter.

  • What is the Analyst Consensus for VYNE Therapeutics, Inc. EPS Next Year?

    VYNE Therapeutics, Inc.'s earnings are forecast to decrease from -$0.94 per share to -$0.89 per share next year representing a decrease of -4.84%.

  • When is VYNE Therapeutics, Inc.'s Earnings Date?

    Currently, VYNE Therapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 6, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Sell
50
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
67
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Sell
39
PSTG alert for Dec 5

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
38
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
69
ASTS alert for Dec 5

AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock